Literature DB >> 10785835

Visual dysfunction in Parkinson's disease.

R L Rodnitzky1.   

Abstract

Several abnormalities of visual function have been demonstrated in Parkinson's disease (PD) by both electrophysiologic and psychophysical testing. Prolonged visual evoked potential latencies and abnormal electroretinographic patterns, both of which respond to levodopa therapy, have been demonstrated in Parkinson's disease patients and in primates with experimental parkinsonism suggesting that retinal dopamine deficiency is an important factor in the pathogenesis of PD visual dysfunction. Abnormalities of color perception, especially in the blue-green axis, and of visual contrast sensitivity (VCS) have also been well documented in PD patients. Although VCS impairment is likely related to retinal dopaminergic dysfunction, the fact that this visual abnormality is orientation-specific raises the possibility of visual cortex involvement as well. Visual abnormalities in PD are usually clinically occult and not likely to be uncovered during a routine neurological examination or by ordinary high contrast visual acuity testing. The clinician must be aware, however, that several forms of disability ranging from gait freezing to visual hallucinations may be linked to an underlying impairment of visual function in Parkinson's disease.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 10785835

Source DB:  PubMed          Journal:  Clin Neurosci        ISSN: 1065-6766


  18 in total

1.  Apathy in Parkinson's disease.

Authors:  G C Pluck; R G Brown
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-12       Impact factor: 10.154

2.  Phosphorylated α-synuclein in the retina is a biomarker of Parkinson's disease pathology severity.

Authors:  Isabel Ortuño-Lizarán; Thomas G Beach; Geidy E Serrano; Douglas G Walker; Charles H Adler; Nicolás Cuenca
Journal:  Mov Disord       Date:  2018-05-08       Impact factor: 10.338

Review 3.  Prefrontal Contributions to Attention and Working Memory.

Authors:  Zahra Bahmani; Kelsey Clark; Yaser Merrikhi; Adrienne Mueller; Warren Pettine; M Isabel Vanegas; Tirin Moore; Behrad Noudoost
Journal:  Curr Top Behav Neurosci       Date:  2019

4.  Potential role of retina as a biomarker for progression of Parkinson's disease.

Authors:  Tian Tian; Xiao-Hua Zhu; Yun-Hai Liu
Journal:  Int J Ophthalmol       Date:  2011-08-18       Impact factor: 1.779

5.  Taste responses in patients with Parkinson's disease.

Authors:  H Sienkiewicz-Jarosz; A Scinska; W Kuran; D Ryglewicz; A Rogowski; E Wrobel; A Korkosz; A Kukwa; W Kostowski; P Bienkowski
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-01       Impact factor: 10.154

6.  ON and OFF channels in human retinal ganglion cells.

Authors:  Takao Hashimoto; Satoshi Katai; Yasunori Saito; Fumitoshi Kobayashi; Tetsuya Goto
Journal:  J Physiol       Date:  2012-10-15       Impact factor: 5.182

Review 7.  The contribution of synaptic plasticity in the basal ganglia to the processing of visual information.

Authors:  I G Sil'kis
Journal:  Neurosci Behav Physiol       Date:  2007-10

8.  Visual perception in prediagnostic and early stage Huntington's disease.

Authors:  Brian F O'Donnell; Tanya M Blekher; Marjorie Weaver; Kerry M White; Jeanine Marshall; Xabier Beristain; Julie C Stout; Jacqueline Gray; Joanne M Wojcieszek; Tatiana M Foroud
Journal:  J Int Neuropsychol Soc       Date:  2008-05       Impact factor: 2.892

Review 9.  Treatment of Visual Disorders in Parkinson Disease.

Authors:  Joseph Savitt; Michaela Mathews
Journal:  Curr Treat Options Neurol       Date:  2018-06-23       Impact factor: 3.598

10.  Visual symptoms in Parkinson's disease.

Authors:  R A Armstrong
Journal:  Parkinsons Dis       Date:  2011-05-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.